Cobra Biologics Holding AB, commonly referred to as Cobra Biologics, is a leading contract development and manufacturing organisation (CDMO) headquartered in Sweden. Established in 2003, the company has made significant strides in the biopharmaceutical industry, specialising in the production of plasmid DNA, viral vectors, and cell and gene therapies. With operational facilities in Sweden and the United Kingdom, Cobra Biologics is well-positioned to serve a global clientele. The company is renowned for its commitment to quality and innovation, offering bespoke solutions that cater to the unique needs of its partners. Cobra Biologics has achieved notable milestones, including successful collaborations with prominent biotech firms, solidifying its reputation as a trusted partner in the development of advanced therapeutics. With a focus on cutting-edge technologies and regulatory compliance, Cobra Biologics continues to play a pivotal role in the evolving landscape of biologics manufacturing.
We don't have data for Cobra Biologics Holding Ab, but we can show you information about their parent organization instead.
View parent company